Patent · US Active

Transdermal therapeutic patches containing 4-N-butylresorcinol

US9801971B2 · kind B2 · utility

0Cited by
9References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 14, 2010
Grant dateOct 31, 2017
Priority date
Expiry dateJul 14, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2300/404
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Transdermal therapeutic systems that contain 4-n-butylresorcinol as an active ingredient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.